Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease

Veterinary Journal

Volumn 202, Issue 3, 2014, Pages 466-470

  Ballin, Anne C ^a   Schulz, Bianka ^a   Helps, Christopher ^b   Sauter Louis, Carola ^a   Mueller, Ralf S ^a   Hartmann, Katrin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antiviral chemotherapy; Feline calicivirus; Feline herpesvirus; FURTD; Interferon

Indexed keywords

ANTIBIOTIC AGENT; CHAMOMILE; EXPECTORANT AGENT; PLACEBO; RECOMBINANT FELINE INTERFERON OMEGA; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; INTERFERON; INTERFERON OMEGA 1; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CALICIVIRUS; CAT; CONJUNCTIVA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FELINE HERPESVIRUS 1; GENE DOSAGE; HERPES VIRUS; NONHUMAN; OROPHARYNX; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; UPPER RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS SHEDDING; ANIMAL; CAT DISEASES; DRUG EFFECTS; FELINE CALICIVIRUS; FEMALE; GERMANY; ISOLATION AND PURIFICATION; MALE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; TOPICAL DRUG ADMINISTRATION; VETERINARY; VIROLOGY;

FELID HERPESVIRUS 1; FELIDAE; FELINE CALICIVIRUS;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIVIRAL AGENTS; CALICIVIRUS, FELINE; CAT DISEASES; CATS; DOUBLE-BLIND METHOD; FEMALE; GERMANY; INTERFERON TYPE I; MALE; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RESPIRATORY TRACT INFECTIONS; VIRUS SHEDDING;

EID: 84919334927     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.09.030     Document Type: Article

References (40)

1. Binns S.H., Dawson S., Speakman A.J., Cuevas L.E., Hart C.A., Gaskell C.J., Morgan K.L., Gaskell R.M. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. Journal of Feline Medicine and Surgery 2000, 2:123-133.
2. Bosio E., Beilharz M.W., Watson M.W., Lawson C.M. Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. Journal of Interferon and Cytokine Research 1999, 19:869-876.
3. Buckwold V.E., Lang W., Scribner C., Blanchett D., Alessi T., Langecker P. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells. Basic and Clinical Pharmacology and Toxicology 2006, 99:62-70.
4. de Mari K., Maynard L., Sanquer A., Lebreux B., Eun H.M. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. Journal of Veterinary Internal Medicine 2004, 18:477-482.
5. Di Martino B., Di Francesco C.E., Meridiani I., Marsilio F. Etiological investigation of multiple respiratory infections in cats. New Microbiologica 2007, 30:455-461.
6. Fulton R.W., Burge L.J. Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons. Antimicrobial Agents and Chemotherapy 1985, 28:698-699.
7. Gaskell R., Dawson S., Radford A., Thiry E. Feline herpesvirus. Veterinary Research 2007, 38:337-354.
8. Gaskell R.M., Povey R.C. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Veterinary Record 1977, 100:128-133.
9. Haid C., Kaps S., Gonczi E., Hassig M., Metzler A., Spiess B.M., Richter M. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats. Veterinary Ophthalmology 2007, 10:278-284.
10. Hartmann K., Kuffer M. Karnofsky's score modified for cats. European Journal of Medical Research 1998, 3:95-98.
11. Helps C., Harbour D. Detection of nucleotide polymorphisms in feline calicivirus isolates by reverse transcription PCR and a fluorescence resonance energy transfer probe. Journal of Virological Methods 2003, 109:261-263.
12. Helps C., Reeves N., Egan K., Howard P., Harbour D. Detection of Chlamydophila felis and feline herpesvirus by multiplex real-time PCR analysis. Journal of Clinical Microbiology 2003, 41:2734-2736.
13. Helps C.R., Lait P., Damhuis A., Bjornehammar U., Bolta D., Brovida C., Chabanne L., Egberink H., Ferrand G., Fontbonne A., et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: Experience from 218 European catteries. Veterinary Record 2005, 156:669-673.
14. Hennet P.R., Camy G.A., McGahie D.M., Albouy M.V. Comparative efficacy of a recombinant feline interferon omega in refractory cases of calicivirus-positive cats with caudal stomatitis: A randomised, multi-centre, controlled, double-blind study in 39 cats. Journal of Feline Medicine and Surgery 2011, 13:577-587.
15. Kaido T.J. Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases. Journal of Interferon and Cytokine Research 1997, 17:31-36.
16. Knebl, A.C., Schulz, B., Helps, C., Sauer-Louis, C., Mueller, R.S., Hartmann, K., 2013. Wirksamkeit von felinem Interferon-omega bei akutem viralem Katzenschnupfen. Abstracts of the 21st Annual Conference on Internal Medicine and Clinical Pathology of the German Society of Veterinary Medicine, Munich, 1-2 February 2013, Tieraerztliche Praxis Kleintiere 41, A10.
17. Knebl A.C., Schulz B., Helps C., Sauer-Louis C., Mueller R.S., Hartmann K. Efficacy of local application of feline interferon-omega in cats with acute viral upper respiratory tract disease. Oral Research Communications at the 23rd ECVIM-CA Congress, Liverpool, 12-14 September 2013. Journal of Veterinary Internal Medicine 2014, 28:729.
18. Knowles J.O., McArdle F., Dawson S., Carter S.D., Gaskell C.J., Gaskell R.M. Studies on the role of feline calicivirus in chronic stomatitis in cats. Veterinary Microbiology 1991, 27:205-219.
19. Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Current Opinion in Immunology 2002, 14:432-436.
20. Mochizuki M., Nakatani H., Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Veterinary Microbiology 1994, 39:145-152.
21. Ohe K., Takahashi T., Hara D., Hara M. Sensitivity of FCV to recombinant feline interferon (rFeIFN). Veterinary Research Communications 2008, 32:167-174.
22. Oritani K., Kincade P.W., Zhang C., Tomiyama Y., Matsuzawa Y. Type I interferons and limitin: A comparison of structures, receptors, and functions. Cytokine and Growth Factor Reviews 2001, 12:337-348.
23. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., Day M.J. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. Journal of Veterinary Internal Medicine 2005, 19:644-653.
24. Povey R.C., Hale C.J. Experimental infections with feline caliciviruses (picornaviruses) in specific-pathogen-free kittens. Journal of Comparative Pathology 1974, 84:245-256.
25. Radford A.D., Coyne K.P., Dawson S., Porter C.J., Gaskell R.M. Feline calicivirus. Veterinary Research 2007, 38:319-335.
26. Randall R.E., Goodbourn S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. Journal of General Virology 2008, 89:1-47.
27. Salazar-Mather T.P., Ishikawa R., Biron C.A. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. Journal of Immunology 1996, 157:3054-3064.
28. Sandmeyer L.S., Keller C.B., Bienzle D. Effects of interferon-alpha on cytopathic changes and titers for feline herpesvirus-1 in primary cultures of feline corneal epithelial cells. American Journal of Veterinary Research 2005, 66:210-216.
29. Schellekens H., Geelen G., Meritet J.F., Maury C., Tovey M.G. Oromucosal interferon therapy: Relationship between antiviral activity and viral load. Journal of Interferon and Cytokine Research 2001, 21:575-581.
30. Siebeck N., Hurley D.J., Garcia M., Greene C.E., Kostlin R.G., Moore P.A., Dietrich U.M. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1. American Journal of Veterinary Research 2006, 67:1406-1411.
31. Slack J.M., Stiles J., Leutenegger C.M., Moore G.E., Pogranichniy R.M. Effects of topical ocular administration of high doses of human recombinant interferon alpha-2b and feline recombinant interferon omega on naturally occurring viral keratoconjunctivitis in cats. American Journal of Veterinary Research 2013, 74:281-289.
32. Thiry E., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., et al. Feline herpesvirus infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery 2009, 11:547-555.
33. Tiefenbrun N., Melamed D., Levy N., Resnitzky D., Hoffman I., Reed S.I., Kimchi A. Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Molecular and Cellular Biology 1996, 16:3934-3944.
34. Tompkins W.A. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: Mechanism of action. Journal of Interferon and Cytokine Research 1999, 19:817-828.
35. Tovey M.G., Maury C. Oromucosal interferon therapy: Marked antiviral and antitumor activity. Journal of Interferon and Cytokine Research 1999, 19:145-155.
36. Uchino T., Ishii S., Inoue K., Inoue M., Uno T., Okusa K., Obayasi K., Okuda A., Kanemoto I., Kanakura H., et al. A large-scale field study of feline interferon on feline calicivirus infection. Japanese Journal of Small Animal Practice 1999, 18:7-17.
37. Verneuil M. Topical application of feline interferon omega in the treatment of herpetic keratitis in the cat: Preliminary study. Proceedings of the International Veterinary Ophthalmology Meeting 2004, 427. Munich, Germany.
38. Wardley R.C. Feline calicivirus carrier state. A study of the host/virus relationship. Archives of Virology 1976, 52:243-249.
39. Wardley R.C., Povey R.C. The clinical disease and patterns of excretion associated with three different strains of feline caliciviruses. Research in Veterinary Science 1977, 23:7-14.
40. Weigler B.J., Babineau C.A., Sherry B., Nasisse M.P. High sensitivity polymerase chain reaction assay for active and latent feline herpesvirus-1 infections in domestic cats. Veterinary Record 1997, 140:335-338.